Correlation of neurological soft signs and neurocognitive performance in first episode psychosis

Psychiatry Research

Volumn 220, Issue 1-2, 2014, Pages 81-88

  Arabzadeh, Somaye ^a   Amini, Homayoun ^a,b   Tehrani Doost, Mehdi ^a   Sharifi, Vandad ^a,b   Noroozian, Maryam ^a,b   Rahiminejad, Fatemeh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Executive function; Neurologic signs; Neuropsychological tests; Psychotic disorders; Schizophrenia; Working memory

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; ARTICLE; ATTENTION; CAMBRIDGE NEUROPSYCHOLOGICAL TEST AUTOMATED BATTERY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; EXECUTIVE FUNCTION; FEMALE; HUMAN; MALE; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; NEUROLOGICAL EVALUATION SCALE; NEUROPSYCHOLOGICAL TEST; PSYCHOSIS; SCORING SYSTEM; SPATIAL MEMORY; VISUAL MEMORY; WORKING MEMORY; COGNITION DISORDERS; COMPLICATION; NERVOUS SYSTEM DISEASES; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; SHORT TERM MEMORY;

ADULT; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; NERVOUS SYSTEM DISEASES; PSYCHOMOTOR PERFORMANCE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84908225806     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.07.044     Document Type: Article

References (74)

1. Abbo C.D., Okello E.S.D., Musisi S.P., Waako P.A.P., Ekblad S.A.P. Naturalistic outcome of treatment of psychosis by traditional healers in Jinja and Iganga districts, Eastern Uganda - a 3- and 6 months follow up. International Journal of Mental Health Systems 2012, 6:13.
2. Albus M., Hubmann W., Mohr F., Hecht S., Hinterberger-Weber P., Seitz N.N., Kuchenhoff H. Neurocognitive functioning in patients with first-episode schizophrenia: results of a prospective 5-year follow-up study. European Archives of Psychiatry and Clinical Neuroscience 2006, 256:442-451.
3. Amminger G.P., Edwards J., Brewer W.J., Harrigan S., McGorry P.D. Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia. Schizophrenia Research 2002, 54:223-230.
4. Arango C., Bartko J.J., Gold J.M., Buchanan R.W. Prediction of neuropsychological performance by neurological signs in schizophrenia. The American Journal of Psychiatry 1999, 156:1349-1357.
5. Arango C., Kirkpatrick B., Buchanan R.W. Neurological signs and the heterogeneity of schizophrenia. The American Journal of Psychiatry 2000, 157:560-565.
6. Ashby F.G., Ell S.W., Valentin V.V., Casale M.B. FROST: a distributed neurocomputational model of working memory maintenance. Journal of Cognitive Neuroscience 2005, 17:1728-1743.
7. Bachmann S., Bottmer C., Schroder J. Neurological soft signs in first-episode schizophrenia: a follow-up study. The American Journal of Psychiatry 2005, 162:2337-2343.
8. Barnes T.R., Hutton S.B., Chapman M.J., Mutsatsa S., Puri B.K., Joyce E.M. West London first-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis. The British Journal of Psychiatry 2000, 177:207-211.
9. Barrera A., Mckenna P.J., Berrios G.E. Formal thought disorder in schizophrenia: an executive or a semantic deficit?. Psychological Medicine 2005, 35:121-132.
10. Bartok E., Berecz R., Glaub T., Degrell I. Cognitive functions in prepsychotic patients. Progress in Neuro-psychopharmacology & Biological Psychiatry 2005, 29:621-625.
11. Becker H.E., Nieman D.H., Wiltink S., Dingemans P.M., van de Fliert J.R., Velthorst E., de Haan L., van Amelsvoort T.A., Linszen D.H Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration?. Psychological Medicine 2010, 40:1599-1606.
12. Behere R.V. Dorsolateral prefrontal lobe volume and neurological soft signs as predictors of clinical social and functional outcome in schizophrenia: A longitudinal study. Indian Journal of Psychiatry 2013, 55:111-116.
13. Bombin I., Arango C., Buchanan R.W. Significance and meaning of neurological signs in schizophrenia: two decades later. Schizophrenia Bulletin 2005, 31:962-977.
14. Borgwardt S.J., McGuire P.K., Aston J., Berger G., Dazzan P., Gschwandtner U., Pfluger M., D'Souza M., Radue E.W., Riecher-Rossler A. Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis. The British Journal of Psychiatry Supplement 2007, 51:s69-s75.
15. Bottmer C., Bachmann S., Pantel J., Essig M., Amann M., Schad L.R., Magnotta V., Schroder J. Reduced cerebellar volume and neurological soft signs in first-episode schizophrenia. Psychiatry Research 2005, 140:239-250.
16. Buchanan R.W., Heinrichs D.W. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Research 1989, 27:335-350.
17. Chan R.C., Wang Y., Wang L., Chen E.Y., Manschreck T.C., Li Z.J., Yu X., Gong Q.Y. Neurological soft signs and their relationships to neurocognitive functions: a re-visit with the structural equation modeling design. PLoS One. e8469 2009, 4.
18. Clark L., Roiser J.P., Cools R., Rubinsztein D.C., Sahakian B.J., Robbins T.W. Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology (Berl) 2005, 182:570-578.
19. Dazzan P., Murray R.M. Neurological soft signs in first-episode psychosis: a systematic review. The British Journal of Psychiatry Supplement 2002, 43:s50-s57.
20. Elliott R., Sahakian B.J. The neuropsychology of schizophrenia: relations with clinical and neurobiological dimensions. Psychological Medicine 1995, 25:581-594.
21. Emsley R., Turner H.J., Oosthuizen P.P., Carr J. Neurological abnormalities in first-episode schizophrenia: temporal stability and clinical and outcome correlates. Schizophrenia Research 2005, 75:35-44.
22. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV) 1996, American Psychiatric Press, Inc., Washington, D.C.
23. Flashman L.A., Flaum M., Gupta S., Andreasen N.C. Soft signs and neuropsychological performance in schizophrenia. The American Journal of Psychiatry 1996, 153:526-532.
24. Fornito A., Harrison B.J., Goodby E., Dean A., Ooi C., Nathan P.J., Lennox B.R., Jones P.B., Suckling J., Bullmore E.T. Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis. JAMA Psychiatry 2013, 70:1143-1151.
25. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. The American Journal of Psychiatry 1996, 153:321-330.
26. Green M.F., Kern R.S., Braff D.L., Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophrenia Bulletin 2000, 26:119-136.
27. Gupta S., Andreasen N.C., Arndt S., Flaum M., Schultz S.K., Hubbard W.C., Smith M. Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. The American Journal of Psychiatry 1995, 152:191-196.
28. Guy W. ECDEU assessment manual for psychopharmacology (DOTES: dosage record and treatmenteEmergent symptom scale) 1976, National Institute of Mental Health, Rockville.
29. Heinrichs D.W., Buchanan R.W. Significance and meaning of neurological signs in schizophrenia. The American Journal of Psychiatry 1988, 145:11-18.
30. Huddy V.C., Aron A.R., Harrison M., Barnes T.R., Robbins T.W., Joyce E.M. Impaired conscious and preserved unconscious inhibitory processing in recent onset schizophrenia. Psychological Medicine 2009, 39:907-916.
31. Hutton S.B., Puri B.K., Duncan L.J., Robbins T.W., Barnes T.R., Joyce E.M. Executive function in first-episode schizophrenia. Psychological Medicine 1998, 28:463-473.
32. Jahn T., Cohen R., Hubmann W., Mohr F., Kohler I., Schlenker R., Niethammer R., Schroder J. The Brief Motor Scale (BMS) for the assessment of motor soft signs in schizophrenic psychoses and other psychiatric disorders. Psychiatry Research 2006, 142:177-189.
33. Janssen J., Diaz-Caneja A., Reig S., Bombin I., Mayoral M., Parellada M., Graell M., Moreno D., Zabala A., Garcia Vazquez G., Desco M., Arango C. Brain morphology and neurological soft signs in adolescents with first-episode psychosis. The British Journal of Psychiatry 2009, 195:227-233.
34. Keefe R.S. Cognitive deficits in patients with schizophrenia: effects and treatment. Journal of Clinical Psychiatry 2007, 68(Suppl, 14):8-13.
35. Kerns J.G., Berenbaum H. Cognitive impairments associated with formal thought disorder in people with schizophrenia. Journal of Abnormal Psychology 2002, 111:211-224.
36. King D.J., Wilson A., Cooper S.J., Waddington J.L. The clinical correlates of neurological soft signs in chronic schizophrenia. The British Journal of Psychiatry 1991, 158:770-775.
37. Kolakowska T., Williams A.O., Jambor K., Ardern M. Schizophrenia with good and poor outcome. III: neurological 'soft' signs, cognitive impairment and their clinical significance. The British Journal of Psychiatry 1985, 146:348-357.
38. Lencz T., Smith C.W., McLaughlin D., Auther A., Nakayama E., Hovey L., Cornblatt B.A. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biological Psychiatry 2006, 59:863-871.
39. Liddle P.F. Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychological Medicine 1987, 17:49-57.
40. Malla A.K., Norman R.M., Aguilar O., Cortese L. Relationship between neurological 'soft signs' and syndromes of schizophrenia. Acta Psychiatrica Scandinavica 1997, 96:274-280.
41. Merriam A.E., Kay S.R., Opler L.A., Kushner S.F., Van Praag H.M. Neurological signs and the positive-negative dimension in schizophrenia. Biological Psychiatry 1990, 28:181-192.
42. Mohr F., Hubmann W., Albus M., Franz U., Hecht S., Scherer J., Binder J., Sobizack N. Neurological soft signs and neuropsychological performance in patients with first episode schizophrenia. Psychiatry Research 2003, 121:21-30.
43. Mohr F., Hubmann W., Cohen R., Bender W., Haslacher C., Honicke S., Schlenker R., Wahlheim C., Werther P. Neurological soft signs in schizophrenia: assessment and correlates. European archives of psychiatry and clinical neuroscience 1996, 246:240-248.
44. Niendam T.A., Lesh T.A., Yoon J., Westphal A.J., Hutchison N., Daniel Ragland J., Solomon M., Minzenberg M., Carter C.S. Impaired context processing as a potential marker of psychosis risk state. Psychiatry Research 2013, 10.1016/j.pscychresns.2013.09.001.
45. Niendam T.A., Lesh T.A., Yoon J., Westphal A.J., Hutchison N., Daniel Ragland J., Solomon M., Minzenberg M., Carter C.S. Impaired context processing as a potential marker of psychosis risk state. Psychiatry Research: Neuroimaging 2014, 221(1):13-20.
46. Nieuwenstein M.R., Aleman A., De Haan E.H. Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin card sorting test. Continuous performance test. Journal of Psychiatric Research 2001, 35:119-125.
47. Ozgurdal S., Littmann E., Hauser M., von Reventlow H., Gudlowski Y., Witthaus H., Heinz A., Juckel G. Neurocognitive performances in participants of at-risk mental state for schizophrenia and in first-episode patients. Journal of Clinical and Experimental Neuropsychology 2009, 31:392-401.
48. Pantelis C., Stuart G.W., Nelson H.E., Robbins T.W., Barnes T.R. Spatial working memory deficits in schizophrenia: relationship with tardive dyskinesia and negative symptoms. The American Journal of Psychiatry 2001, 158:1276-1285.
49. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., Yung A.R., Bullmore E.T., Brewer W., Soulsby B., Desmond P., McGuire P.K. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003, 361:281-288.
50. Pantelis C., Velakoulis D., Wood S.J., Yucel M., Yung A.R., Phillips L.J., Sun D.Q., McGorry P.D. Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. International Review of Psychiatry 2007, 19:371-381.
51. Pantelis C., Wood S.J., Proffitt T.M., Testa R., Mahony K., Brewer W.J., Buchanan J.A., Velakoulis D., McGorry P.D. Attentional set-shifting ability in first-episode and established schizophrenia: relationship to working memory. Schizophrenia Research 2009, 112:104-113.
52. Pantelis C., Yucel M., Wood S.J., McGorry P.D., Velakoulis D. Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. The Australian and New Zealand Journal of Psychiatry 2003, 37:399-406.
53. Pantelis C., Yucel M., Wood S.J., Velakoulis D., Sun D., Berger G., Stuart G.W., Yung A., Phillips L., McGorry P.D. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophrenia Bulletin 2005, 31:672-696.
54. Park S. Hemispheric asymmetry of spatial working memory deficit in schizophrenia. International Journal of Psychophysiology 1999, 34:313-322.
55. Park S., Puschel J., Sauter B.H., Rentsch M., Hell D. Spatial working memory deficits and clinical symptoms in schizophrenia: a 4-month follow-up study. Biological Psychiatry 1999, 46:392-400.
56. Perez-Iglesias R., Tordesillas-Gutierrez D., McGuire P.K., Barker G.J., Roiz-Santianez R., Mata I., de Lucas E.M., Rodriguez-Sanchez J.M., Ayesa-Arriola R., Vazquez-Barquero J.L., Crespo-Facorro B. White matter integrity and cognitive impairment in first-episode psychosis. The American Journal of Psychiatry 2010, 167:451-458.
57. Prikryl R., Ceskova E., Tronerova S., Kasparek T., Kucerova H.P., Ustohal L., Venclikova S., Vrzalova M. Dynamics of neurological soft signs and its relationship to clinical course in patients with first-episode schizophrenia. Psychiatry Research 2012, 200:67-72.
58. Quitkin F., Rifkin A., Klein D.F. Neurologic soft signs in schizophrenia and character disorders. Organicity in schizophrenia with premorbid asociality and emotionally unstable character disorders. Archives of General Psychiatry 1976, 33:845-853.
59. Rhinewine J.P., Lencz T., Thaden E.P., Cervellione K.L., Burdick K.E., Henderson I., Bhaskar S., Keehlisen L., Kane J., Kohn N., Fisch G.S., Bilder R.M., Kumra S. Neurocognitive profile in adolescents with early-onset schizophrenia: clinical correlates. Biological Psychiatry 2005, 58:705-712.
60. Riley E.M., McGovern D., Mockler D., Doku V.C., S.O.C., Fannon D.G., Tennakoon L., Santamaria M., Soni W., Morris R.G., Sharma T. Neuropsychological functioning in first-episode psychosis--evidence of specific deficits. Schizophrenia Research 2000, 43:47-55.
61. Robbins T.W., James M., Owen A.M., Sahakian B.J., McInnes L., Rabbitt P. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 1994, 5:266-281.
62. Rossi A., De Cataldo S., Di Michele V., Manna V., Ceccoli S., Stratta P., Casacchia M. Neurological soft signs in schizophrenia. The British Journal of Psychiatry 1990, 157:735-739.
63. Salmanian M., Tehrani-Doost M., Ghanbari-Motlagh M., Shahrivar Z. Visual memory of meaningless shapes in children and adolescents with autism spectrum disorders. Iranian Journal of Psychiatry 2012, 7:104-108.
64. Schroder J., Niethammer R., Geider F.J., Reitz C., Binkert M., Jauss M., Sauer H. Neurological soft signs in schizophrenia. Schizophrenia Research 1991, 6:25-30.
65. Sewell R.A., Perry E.B., Karper L.P., Bell M.D., Lysaker P., Goulet J.L., Brenner L., Erdos J., D'souza D.C., Seibyl J.P., Krystal J.H. Clinical significance of neurological soft signs in schizophrenia: factor analysis of the neurological evaluation scale. Schizophrenia Research 2010, 124:1-12.
66. Sharifi V., Assadi S.M., Mohammadi M.R., Amini H., Kaviani H., Semnani Y., Shabani A., Shahrivar Z., Davari-Ashtiani R., Shooshtari M.H., Seddigh A., Jalali M. A Persian translation of the structured clinical interview for diagnostic and statistical manual of mental disorders, fourth edition: psychometric properties. Comprehensive Psychiatry 2009, 50:86-91.
67. Solanki R.K., Swami M.K., Singh P. An examination of relationship between neurological soft signs and neurocognition. Asian Journal of Psychiatry 2012, 5:43-47.
68. Stirling J., Hellewell J., Blakey A., Deakin W. Thought disorder in schizophrenia is associated with both executive dysfunction and circumscribed impairments in semantic function. Psychological Medicine 2006, 36:475-484.
69. Subotnik K.L., Nuechterlein K.H., Green M.F., Horan W.P., Nienow T.M., Ventura J., Nguyen A.T. Neurocognitive and social cognitive correlates of formal thought disorder in schizophrenia patients. Schizophrenia Research 2006, 85:84-95.
70. Summers M.J., Saunders N.L. Neuropsychological measures predict decline to Alzheimer's dementia from mild cognitive impairment. Neuropsychology 2012, 26:498-508.
71. Tosato S., Dazzan P. The psychopathology of schizophrenia and the presence of neurological soft signs: a review. Current Opinion in Psychiatry 2005, 18:285-288.
72. Van der Molen M.J., Huizinga M., Huizenga H.M., Ridderinkhof K.R., Van der Molen M.W., Hamel B.J., Kurfs L.M., Ramakers G.J. Profiling fragile X syndrome in males: strengths and weaknesses in cognitive abilities. Research in Developmental Disabilities 2010, 31:426-439.
73. Whitty P., Clarke M., Browne S., Mctigue O., Kamali M., Feeney L., Lane A., Kinsella A., Waddington J.L., Larkin C., O'callaghan E. Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomena. Psychological Medicine 2003, 33:1479-1484.
74. Wood S.J., Pantelis C., Proffitt T., Phillips L.J., Stuart G.W., Buchanan J.A., Mahony K., Brewer W., Smith D.J., McGorry P.D. Spatial working memory ability is a marker of risk-for-psychosis. Psychological Medicine 2003, 33:1239-1247.